Opengear Further Simplifies IT Management Complexity
8.10.2024 15:00:00 CEST | Business Wire | Press release
Opengear Unveils Advanced Solutions to Streamline IT Management for AI Innovation, Security, and Compliance
Opengear, a Digi International company (NASDAQ, DGII, www.digi.com) and provider of secure and Smart Out of Band management solutions, has introduced two new advanced offerings. These innovative solutions will simplify initial setup with zero-touch provisioning and ensure access to IT infrastructure. Opengear continues to be an IT industry leader by providing a highly secure and easy-to-use management solution that reinforces its commitment to supporting IT professionals around the globe.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241008772657/en/
Opengear Unveils Advanced Solutions to Streamline IT Management for AI Innovation, Security, and Compliance. (Graphic: Business Wire)
Today, Opengear unveiled key enhancements for its Network Resilience Platform. These advanced solutions — Connected Resource Gateway (CRG) and Lighthouse Service Portal (LSP) — dramatically reduce complexity and provide efficiency to IT organizations that are under vast pressure due to increasing demands to deliver results with fewer resources. CRG and LSP simplify the deployment process while providing ease of access, improved security, and simplified management when monitoring and managing IT infrastructure.
Opengear's hybrid cloud model for Lighthouse enables organizations to choose where to use critical applications and services, ensuring they meet regulatory and compliance requirements. As IT complexity increases with growing security, compliance, and AI demands, this hybrid approach mitigates risks while ensuring resilience across IT operations.
Douglas Wadkins, Vice President of Product Management & Strategy, said, “Opengear is committed to delivering solutions that solve real-world challenges. Customers rely on Opengear's solution before their network is operational, when it is unavailable and for everyday IT operations. LSP provides zero-touch provisioning for Opengear appliances and CRG ensures immediate, reliable, and secure access to essential tasks when managing IT infrastructure.”
Connected Resource Gateway (CRG):Simplifying access while strengthening security, CRG streamlines operations for IT teams managing complex infrastructure. It seamlessly integrates with Opengear's Smart Management Fabric (SMF), ensuring a dependable link between network management tools, users, and managed endpoints.
Available via our Lighthouse software solution, CRG now enables IT professionals and networking tools to securely access connected IT resources through a web interface offering serial or IP-based connectivity options. Access is managed through roles, permissions, and attributes, providing flexible and secure connections. It simplifies network management by eliminating the need for complicated client software installations or configurations.
Lighthouse Service Portal (LSP):Designed to simplify the deployment of data center and edge site network infrastructure, LSP streamlines the provisioning of Opengear devices into the Lighthouse software. This cloud-based service easily automates the onboarding of new Opengear appliances. Customers can then leverage configuration management tools and API integrations to push configurations through the Lighthouse Smart Management Fabric and Connected Resource Gateway, completing the provisioning of Opengear appliances and connected network resources.
Available through the Opengear customer portal and in conjunction with Lighthouse, LSP simplifies and secures the enrollment process, providing a smoother, more efficient starting point for IT management.
For more information, request a demo and visit: https://opengear.com/products/lighthouse/. Or please contact your Opengear representative for details.
About Opengear
Opengear, a Digi International company, delivers secure, resilient access and automation to support critical IT infrastructure on the First Day, Worst Day, and Every Day. Through presence and proximity, Opengear solutions enable provisioning, orchestration, and remote management of network devices through innovative software and appliances. Opengear solutions are trusted by global organizations across financial, digital communications, retail, and manufacturing sectors. The company is headquartered in New Jersey, with an R&D center in Brisbane, Australia. For more information, visit www.opengear.com/.
About Digi International
Digi International (NASDAQ: DGII) is a leading global provider of business and mission-critical Internet of Things (IoT) connectivity products and solutions. We help our customers create next-generation connected products and solutions to deploy, monitor, and manage critical communications infrastructures and compliance standards in demanding environments with high levels of security, relentless reliability, and bulletproof performance. Founded in 1985, the company has helped customers connect more than 100 million things — and counting. For more information, visit www.digi.com, or call 877-912-3444 (U.S.) or 952-912-3444 (International).
View source version on businesswire.com: https://www.businesswire.com/news/home/20241008772657/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom